The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion

AUDUBON, N.J. - June 18, 2020 - PRLog -- Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes:

§  A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.

§  Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.

§  A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.

§  A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.

§  A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.

§  A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug / therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.

§  An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.

§  A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.

§  A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.

§  A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.

§  A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CMO services to medical device developers.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

The report also features detailed transcripts of discussions held with the following experts:


For more information please click on the following link:

Biopharma Contract Manufacturing Market (3^rd Edition), 2019-2030 (https://rootsanalysis.com/reports/view_document/biopharma...)

Other Recent Offerings

1.      Cell Therapy Manufacturing Market (3^rd Edition), 2019-2030

2.      Antibody Contract Manufacturing Market, 2020-2030

3.      China Biopharmaceutical Contract Manufacturing Market, 2020-2030

4.      Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com